Single shot could kick the cocaine habit; Sanofi has recalled its TB vaccine in Canada;

> Cocaine addiction can be treated with behavioral modification and support but this is a long and slow process--what if it could be treated with just a single shot? Researchers in the U.S. have developed a virus-based therapeutic that delivers genes coding for a cocaine antibody, which captures the drug and prevents it from crossing the blood-brain barrier. Press release | Paper

> Sanofi has voluntarily recalled its tuberculosis (BCG) vaccine in Canada because of manufacturing issues that could affect the vaccine's quality. Article

> The world's first hepatitis E vaccine, Hecolin, is likely to be launched in China this year, through Xiamen University's Xiamen Innovax Biotech. Article

> Biovest has submitted formal notification to the European Medicines Agency (EMA) of its intent to file a Marketing Authorization Application (MAA) for approval in Europe of BiovaxID, its personalized follicular non-Hodgkin's lymphoma therapeutic vaccine; this could make it the first lymphoma vaccine available in Europe. Press release

> Militants have banned polio vaccination teams in North Waziristan, a region of Pakistan, as a protest against U.S. drone strikes. Article

> Anergis has reached preclinical milestones for its ragweed pollen allergy vaccine, AllerR. Article

> U.S. courts have ruled that Apotex is not infringing Merck's patent with its generic form of NASONEX. Press release

> NovaRx has completed enrollment in its Phase III clinical trial of Lucanix (belagenpumatucel-L), its whole tumor cell vaccine for the treatment of non-small cell lung cancer. Press release

> The CDC has voted to recommend the expanded use of Pfizer's Prevnar 13 vaccine in adults of 19 and older who have compromised immune systems. Article

> Hepatitis B vaccine appears to protect for 25 years, making boosters unnecessary. Article

> Texas A&M has won a federal contract that could be worth $1.5-2 billion over 25 years, to become a national hub of vaccine production and bioterror preparedness. Article

And Finally… Bharat Biotech and the University of Maryland Center's for Vaccine Development (CVD) have received a $4 million Strategic Translation Award from the Wellcome Trust for the clinical development of a vaccine against non-typhoidal Salmonella. Article

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.